Crunch Time For Protection Of New Therapeutic Uses In Europe
EU’s Top Court Given Two Choices On Award Of SPCs
Executive Summary
The pharmaceutical industry will be watching carefully as the EU Court of Justice deliberates on whether to deny or widen the granting of supplementary protection certificates on new therapeutic indications of authorized medicines.